ISSN 1671-5411 CN 11-5329/R
Yong-Yan FAN, Feng XU, Chao ZHU, Wen-Kun CHENG, Jian LI, Zhao-Liang SHAN, Yang LI, Yu-Tang WANG. Effects of febuxostat on atrial remodeling in a rabbit model of atrial fibrillation induced by rapid atrial pacing. J Geriatr Cardiol 2019; 16(7): 540-551. doi: 10.11909/j.issn.1671-5411.2019.07.003
Citation: Yong-Yan FAN, Feng XU, Chao ZHU, Wen-Kun CHENG, Jian LI, Zhao-Liang SHAN, Yang LI, Yu-Tang WANG. Effects of febuxostat on atrial remodeling in a rabbit model of atrial fibrillation induced by rapid atrial pacing. J Geriatr Cardiol 2019; 16(7): 540-551. doi: 10.11909/j.issn.1671-5411.2019.07.003

Effects of febuxostat on atrial remodeling in a rabbit model of atrial fibrillation induced by rapid atrial pacing

doi: 10.11909/j.issn.1671-5411.2019.07.003
Funds:

This study was supported by the Beijing Natural Science Foundation (Z141100002114050)

  • Received Date: 2019-05-27
  • Rev Recd Date: 2019-06-06
  • Publish Date: 2019-07-28
  • Background Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase (XO), may be used in the prevention and man-agement of atrial fibrillation (AF). The purpose of this study was to evaluate the effects of febuxostat on atrial remodeling in a rabbit model of AF induced by rapid atrial pacing (RAP) and the mechanisms by which it acts. Methods Twenty-four rabbits were randomly divided into four groups: sham-operated group (Group S), RAP group (Group P), RAP with 5 mg/kg per day febuxostat group (Group LFP), and RAP with 10 mg/kg per day febuxostat group (Group HFP). All rabbits except those in Group S were subjected to RAP at 600 beats/min for four weeks. The effects of febuxostat on atrial electrical and structural remodeling, markers of inflammation and oxidative stress, and signal-ing pathways involved in the left atrium were examined. Results Shortened atrial effective refractory period (AERP), increased AF induci-bility, decreased mRNA levels of Cav1.2 and Kv4.3, and left atrial enlargement and dysfunction were observed in Group P, and these changes were suppressed in the groups treated with febuxostat. Prominent atrial fibrosis was observed in Group P, as were increased levels of TGF-β1, Collagen I, and α-SMA and decreased levels of Smad7 and eNOS. Treatment with febuxostat attenuated these differences. Changes in inflammatory and oxidative stress markers induced by RAP were consistent with the protective effects of febuxostat. Conclusions This study is the first to find that febuxostat can inhibit atrial electrical and structural remodeling of AF by suppressing XO and inhibiting the TGF-β1/Smad signaling pathway.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (805) PDF downloads(334) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return